Last checked at 28 Jun 2021 17:05
LONDON MARKET CLOSE: Delta variant concerns sink travel stocks
LONDON MARKET CLOSE: Delta variant concerns sink travel stocks
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News
AZN Share
Chat
AZN Share
Trades44,949
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
12,026.00
Bid:
12,008.00
Ask:
12,012.00
Change:
674.00 (5.94%)
Spread:
4.00 (0.033%)
Open:
11,890.00
High:
12,096.00
Low:
11,790.00
Prev. Close:
11,352.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.28 Jun 2021 16:08
UPDATE 1-Immune response of AstraZeneca shot boosted by mixing dose schedule with Pfizer - study
(Adds detail, quote)By Alistair SmoutLONDON, June 28 (Reuters) - A mixed schedule of vaccines where a shot of Pfizer's COVID-19 vaccine is given four weeks after a AstraZeneca shot will produce better immune responses than giving another dose of t...
Read more28 Jun 2021 16:08
UPDATE 2-Mix-and-match approach boosts immune response of AstraZeneca shot, study finds
* Both mixed schedules produced more antibodies than two AZ shots* Results support move towards mix-and-match approach in Europe* Professor: don't abandon clinically approved schedules (Adds official on implications for vaccine rollout)By Alistair...
Read more28 Jun 2021 16:00
Immune response of AstraZeneca shot boosted by mixing dose schedule with Pfizer - study
LONDON, June 28 (Reuters) - A mixed schedule of vaccines where a shot of Pfizer's COVID-19 vaccine is given four weeks after a AstraZeneca shot will produce better immune responses than giving another dose of the AstraZeneca shot, an Oxford study...
Read more28 Jun 2021 15:58
Tennis-Vaccine developer Gilbert among guests given standing ovation at Wimbledon
June 28 (Reuters) - Wimbledon spectators on Monday paid tribute to Sarah Gilbert, the Oxford University professor who co-designed the Oxford/AstraZeneca vaccine, giving her a standing ovation on Centre Court before play began in the annual tennis tou...
Read more28 Jun 2021 15:10
AstraZeneca's India vaccine partner seeking EU travel resolution
By Uday Sampath Kumar and Ankur BanerjeeBENGALURU, June 28 (Reuters) - Serum Institute of India CEO Adar Poonawalla said on Monday he was trying to resolve EU travel problems facing Indians who have been inoculated with SII's licensed version of A...
Read more28 Jun 2021 13:28
Monday broker round-up
(Sharecast News) - St James Place: HSBC downgrades to hold with a target price of 1,525p.
Read more28 Jun 2021 12:37
UPDATE: Astra's vaccine an effective booster; finds new Oncology head
UPDATE: Astra's vaccine an effective booster; finds new Oncology head
Read more28 Jun 2021 12:19
LONDON MARKET MIDDAY: Stocks slide; UK roadmap announcement ahead
LONDON MARKET MIDDAY: Stocks slide; UK roadmap announcement ahead
Read more28 Jun 2021 12:00
Oxford COVID vaccine produces strong immune response from booster shot - study
* No evidence yet that booster shots are needed* Antibodies also higher after greatly delayed second dose* Study helps soothe worries over repeat use of viral vector shotsBy Alistair SmoutLONDON, June 28 (Reuters) - A third shot of the Oxford-Astra...
Read more28 Jun 2021 10:14
AstraZeneca gets EU approval for kidney disease drug Forxiga
AstraZeneca gets EU approval for kidney disease drug Forxiga
Read more28 Jun 2021 07:47
AstraZeneca's Forxiga recommended for EU approval
(Sharecast News) - AstraZeneca said on Monday that 'Forxiga', or dapagliflozin, has been recommended for approval in the European Union for the treatment of chronic kidney disease (CKD) in adults with and without type-2 diabetes (T2D).
Read more27 Jun 2021 19:55
AstraZeneca tests booster jab against South Africa virus variant
AstraZeneca tests booster jab against South Africa virus variant
Read more27 Jun 2021 19:49
Ireland brings forward decision on whether to delay July 5 reopening
Ireland brings forward decision on whether to delay July 5 reopening
Read more27 Jun 2021 11:15
Germany expects faster Moderna COVID-19 vaccine deliveries
BERLIN, June 27 (Reuters) - Germany expects drugmaker Moderna Inc to deliver COVID-19 vaccines faster than expected, helping it ramp up vaccinations in coming months, the health ministry said on Sunday.Moderna will increase its deliveries to 1.33 ...
Read more